Matrubials

Matrubials

Private
Davis, CaliforniaHealthcare & Life Scienceshttps://www.matrubials.com

Last Round

Grant

Dec 4, 2025

Total Funding Raised

$406,968

Company Overview

Matrubials, Inc. is a biotechnology company that develops therapeutics derived from milk peptides to address antimicrobial resistance and other modern diseases. A spin-out from the University of California, Davis, Foods for Health Institute, the company utilizes an AI-enabled platform to identify and validate bioactive molecules. Its initial focus is on developing a topical therapeutic for bacterial vaginosis (BV), a condition affecting millions of women. The company's mission is to provide safe and selective solutions to reduce the health and economic impact of bacterial infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Application

Keywords

bacterial vaginosisBVantimicrobial peptidesmilk peptideswomen's healthfemtechmicrobiome therapeuticsantimicrobial resistanceAMRpeptide therapeuticsvaginal microbiomeAI drug discoverytopical therapeuticanti-infective therapeuticsdrug discovery platformSBIR grant

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Matrubials Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Matrubials Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantDec 4, 2025
GrantJun 1, 2022
GrantMay 10, 2022

Key People

Founding team and executive leadership

Ishita M. Shah

Co-founder And Chief Executive Officer

Founding Team

Matrubials Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 4, 2025

    $50K raised in an angel round.

  • Dec 1, 2025

    Won Audience Choice Award at NorCal AngelCon.

Matrubials Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Matrubials Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Matrubials's valuation, stock price, and market status.

Firmographic Details

HeadquartersDavis, California
Employee Range6
Year Founded2018
Last FundingDec 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.